P
Power Law company profile
Poseida Therapeutics
Biotech & Life Sciences · San Diego, United States · Founded 2015 · IPO 2020 Unicorn
Global footprint
Where Poseida Therapeutics has talent and traffic
AI talent share
0.9%
of workforce is AI talent
(1 of 116 staff)
(1 of 116 staff)
Core AI00%
Other AI10.86%
Non-AI workforce11599.14%
Web traffic by country
3.8K
monthly visits
across markets
across markets
🇺🇸 United States100%
Patent intelligence
$53M patent portfolio · 48 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$53M
6.8% of valuation · 38.1× smaller than top peer Ablynx ($2B)
48 active patent families
Where Poseida Therapeutics innovates
Molecular biologyNucleic acidOrganic chemistryBiochemistryCell therapy
Above peer median on Strategic
Quality vs same-sector peers
Poseida Therapeutics on the five Patsnap quality dimensions
Poseida Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Poseida Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Poseida Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Poseida Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.